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Multiple sclerosis (MS) is an inflammatory demyelinating disease of central 
nervous system (CNS) that is increasingly being recognized as a disease affecting 
children. However, the clinical features of childhood MS at onset have been 
rarely reported from Asia.
Materials & Methods
This report presents a retrospective chart review of 26 patients with MS (20 
females and 6 males), with an onset age of MS of less than 16 years, in the south 
of Iran between March 2001and November 2007; it documents researchers’ 
experiences
Results
Female/male ratio was 3:1. Mean age in females was higher than males (13 
vs.12.16).The disease was highly variable in onset presentation; the most 
common initial symptoms were limb weakness, disequilibrium, and diplopia. 
Three patients had a positive family history of MS in their first degree relatives. 
VEP was abnormal in 9 of 19(47%). MRI demonstrated multiple plaques in the 
brain in 24(92%) cases. Relapse remitting MS was a dominant pattern noticed 
in 23(88%) cases.
Conclusion
MS, in childhood, is not as rare as commonly believed; although its diagnosis 
is essentially a clinical one, paraclinical investigations are of great value in the 
identification of demyelinating disorders in childhood. The disease, as it occurs 
in children, does not appear to differ clinically from the disease as observed in 
adults. If pediatricians should confront a child showing evidence of scattered 
neurological deficits that remit, particularly weakness, disturbance of vision and 
co-ordination, they need to consider the possibility of MS.
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Introduction
Multiple sclerosis (MS) is a chronic autoimmune inflammatory demyelinating 
disease of central nervous system (CNS) that is increasingly being recognized as 
a disease affecting children (1). The occurrence of MS in children has been the 
subject of recurring discussions for over 80 years (2); the controversy that existed 
at the beginning of 20th century on the possibility that the MS occurs in childhood 
probably arose because MS is primarily a disease of young adulthood with a clinical 
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onset usually occurring between 20 and 40 years of age 
(3,4). Numerous studies indicate an average age at onset 
of 30 years, but the span is considerable and diagnostic 
criteria now include the possibility that the disease may 
become manifest between the ages of 10 and 59 years 
(4,5). Even so, clinical onset at an earlier (or later) age 
is no reason to exclude the diagnosis of MS; however, 
in 3 to 5% of cases, MS begins before the age of 15 (5). 
McAlpine, combined data from a number of studies 
from various countries (5700 patients) and showed that 
incidence of MS before age 10 years was less than 3 per 
1000 (6). Muller reported of 810 cases from Sweden and 
noted that in 46 patients (5.6%), the onset was before 15 
years of age (7).The youngest known patient with MS 
yet described was a 24 month old child (8). Hauser et 
al. reported a child with onset of MS at 2 years of age 
(9) and Di Mario et al. presented a 4 year-old child with 
MS and typical clinical and nuclear magnetic resonance 
imaging(MRI) correlations (10). As onset of this disease 
can be delayed till 60s and 70s. There are very few 
disease with such a wide range of onset.
Since the clinical features of childhood MS at onset in 
Asia have been rarely reported, and there is a lack of 
awareness among pediatricians as to the occurrence of 
MS in children; our intention was to review our own 
observations of clinical and paraclinical features in 
patients whose symptoms started before 16 years of age 
(11). Most frequently a meticulous, time consuming and 
costly search for metabolic and degenerative disorders 
is initiated before the diagnosis of MS is considered, 
leading to a significant diagnostic and therapeutic delay 
in many young patients.
Materials & Methods
This report presents researchers’ experience using a 
retrospective chart review of 26 patients with MS (20 
females and 6 males) with onset age before 16 years 
(mean age of 11.8 +/-2.7 years), admitted to the Nemazee 
hospital, a referred hospital in south of Iran in Fars province, 
Shiraz, between March 2001 and November 2007 and 
can thus be considered as representative of MS occurring 
in childhood. Particular attention was given to exclude 
other diseases such as post infectious encephalomyelitis, 
acute disseminated encephalomyelitis, vasculitis and 
other demyelinating disorders. As a consequence, 
questionable or borderline cases were excluded. Data 
analyzed were sex and age distribution at onset, initial 
symptoms, symptoms occurring in the course of illness, 
physical findings, family history, clinical course, rate 
of relapses, cerebrospinal fluid (CSF) analysis result, 
magnetic resonance imaging (MRI) result, visual evoke 
potential (VEP) result, other laboratory studies and 
the treatments applied. All patients had clinically been 
defined as MS according to Poser’s criteria (12), viz. 
a history of two attacks and clinical evidence of two 
separate lesions or two attacks, clinical evidence of one 
lesion and paraclinical evidence of another, separate 
lesion (4). Family history was considered positive if a 
first or second degree relative was reported or known to 
have MS. Statistical analysis was performed by statistical 
software SSPS version 9 after encoding and got entering 
to computer and necessary information was obtained.
Results
Age and Sex Distribution
Of a group of 26 patients, 20 were girls (76%) and 6 
boys (24%); female/male ratio was 3:1. Significant sex 
related differences in the symptoms, signs, or course 
of the disease were not noted. Age at the onset of the 
neurological symptoms ranged from 6 to 16 years. The 
two youngest patients were aged 6 and 8 years, both 
males, while the three youngest female patients were 
aged 9. The mean age at onset was 11.8 years. The 
mean age in females was higher than in males (13.2 vs. 
12.3). Nineteen (76%) of the patients were aged over 12 
years.
Symptoms at Onset
The disease was highly variable in presentation at onset. 
In the majority of cases physical symptoms were not 
present at onset of disease; the patient simply became 
aware of the gradual or sudden appearance of an 
impairment of neurologic function. In 17 patients (65%), 
mode of onset was rapid or with sudden appearance 
within a few days, especially when visual symptoms were 
the initial chief complaint; in 9 cases (36%) however, the 
development of initial symptoms mainly weakness in a 
limb occurred so gradually that no definite date of onset 
could be determined. In five cases, the initial episode 
was accompanied by one or more of the following 
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symptoms: mild headache in 3, nausea and vomitting in 
4, drowsiness in 3 and dysequilibrium (dizziness or true 
vertigo) in 2 and fever in one case.
The initial clinical manifestations, in decreasing order 
of frequency were limb weakness in 19 cases (73%), 
diplopia in 8 (30%), ataxia or incoordination in 8 (27%), 
blurred vision in 6 (23%), sensation loss in 5 (19%) and 
sphincter problems in one case (4%). 
Symptoms occurring within study period
Symptoms seen during the clinical course of illness, in 
order of decreasing frequency were: limb weakness in 
21 cases (80%), sensation loss in 16 (61%), ataxia and 
incoordination in 14 (53%), blurred vision in 13 50%), 
diplopia in 9 (34%), nystagmus in 4 (15%), sphincter 
problems in 4 (15%), facial palsy in 3 (11%), limb 
neglection in one (4%), seizure in one (4%), emotional 
stress attacks in one (4%) and confusion in one case 
(4%).
In one patient (4%) episodes suggesting convulsion 
occurred, apparently they were not associated with any 
other neurologic deficit at the time of the seizure.
Physical Findings
Muscle weakness was observed in 21 cases (84%); both 
legs were involved in 15 cases (60%) one leg in 5 (20%), 
both arms in cases (44%) and one arm in 8 (32%) cases. 
Ataxic gait and incoordination was observed in 8 cases 
(30.7%). Babinski’s reflex was present in 5 cases (25%). 
Hyper-reflexia was seen in deep tendon reflexes (DTR) 
of 10 cases (40%). Hypo-reflexia was seen in DTRs of 
4 cases (16%).
Fourteen patients (56 exhibited abnormalities of visual 
apparatus. Optic neuritis was present in 5 patients (20%) 
and optic atrophy was present in 3 patients (12%), of 
which one patient had previous attack of optic neuritis 
that had not been recognized and had recently presented 
with motor symptoms, with optic atrophy being detected 
incidentally. Facial palsy was seen in 3 cases (12%). 
Impaired gag reflex (cranial nerve IX) was seen in two 
cases (8%). Right V and VI cranial nerve palsy was seen 
in 2 patients (8%). Impairment of cranial nerves X and 
XII was seen in one patient (4%).
Sensory level was found in 4 patients (16%). Romberg’s 
and Hoffmann’s sign was observed to be positive in 
2 patients (8%). Lhermitte’s sign was observed to be 
positive in two patients (7.6%).
Disatometamyelia and diabetes mellitus was seen in one 
patient each.
Three patients had a positive family history of MS in first 
degree relatives. Other family histories were: migrain 
headaches, cerebral palsy, and diabetes mellitus in one 
patient each.
Twenty-three patients (88%) had a relapsing and 
remitting disease, two patients had primary progressive 
disease (7%) and one patient had chronic progressive 
disease (4%). Over all the mean rate of relapses/year was 
0.50 per year. 
A fifteen year-old female patient who had the primary 
progressive pattern of the disease, became handicapped 
and bed-ridden and attempted suicide due to deep 
depression; she died due to aspiration pneumonia and 
sepsis because of multiple deep bed-sores, resulting in 
cardiopulmonary arrest; the relapse rate for this patient 
was 1.25 per year. Another nine year-old female patient, 
also with the primary progressive pattern of the disease, 
also became handicapped, completely dependent on 
others for walking; follow up data was not available for 
this patient and the relapse rate for this patient was 1 per 
year. Another 15 year-old female patient with the chronic 
progressive pattern of the disease developed weakness, 
ataxia and optic neuritis with increasing frequency of 
attacks over five years; however this did not lead to any 
severe disability within the study period; relapse rate for 
this patient was 0.6 per year.
Laboratory studies on cerebrospinal fluid were 
performed in all the patients. The fluid was normal in 
only one instance (proteins, cell counts). The specimens 
in these cases contained one to 24 leukocytes and had 
one to 11 lymphocytes. The fluid from 6 patients (23%) 
contained abnormal amounts of protein concentrations, 
over 40 mg/100 ml. The IgG levels in CSF were 
available for 2 patients, normal in one and high in the 
other. Electrophoresis was available for only 3 patients, 
being abnormal in one patient. Vasculitis work ups, such 
as Anti Nnuclear Antibody (ANA), Double strand DNA, 
Anti-Neutrophil Cytoplasmic Antibody (ANCA), Anti-
Cardiolipin Antibody (ACLA), C3, C4 was done in 17 
patients (68%), being positive in one patient; a repeat 
of the test, gave normal results. Serum was checked for 
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anti smooth muscle antibody in one patient, human 
T-lymphocyte virus 1 (HTLV1) antibody in one patient, 
VDRL in one patient, proC and proA in one patient (4%) 
and all results were negative. Folic acid and Vit B levels 
in serum were checked in one patient and were normal. 
The patients had no clinical finding of vasculitis.
Brain MRIs, using the T2 and T1 techniques with or 
without contrast were performed in all the patients 
(100%). All plaques were detected as multiple 
hypersignal areas of  white matter in T2 and hyposignal 
in T1 which were disseminated in space. The most 
common sites involved in order of decreasing frequency 
are seen in figure1.
Visual evoke potential was done in 19 cases (76%) and 
was abnormal with prolonged latency in 9 cases (48%). 
Bilateral impaired VEP was seen in 6 cases (31%). 
In 4 cases who had bilateral prolong latency, normal 
fundoscopy was found.
Treatments prescribed for acute attacks of MS, in order 
of decreasing frequency, were methylprednisolone in 20 
patients (76%), dexamethazone in 4 patients (15%) and 
IV IG in two patients (7%), plasmaphoresis in one patient 
(4%). After treatment of acute attack, prophylaxis for 
prevention recurrence of attack was used in 9 patients. 
INF-B 1a (Avonex) injection was administered in 8 
patients (3 0%) and Rebif was used in one patient (4%) 
because the response to Avonex injection was not good 
and weakness had developed.
Discussion
We have presented the clinical and paraclinical data of 
26 patients with MS, with an onset of disease before 
16 years of age; the results can thus be considered as 
representative of MS in childhood from the region 
studied.
The prevalence of multiple sclerosis (MS) worldwide 
shows considerable variability. According to Kurtzke, 
Iran is considered to have a low prevalence. Kalanie 
H& et al reviewed 200 cases of MS in Tehran (13) 
Etemadifar M& et al showed that Isfahan (a big city 
in center of Iran) could be considered as an area with a 
medium to high risk of MS. [14]. A 3-year study, done by 
Ghofrani M& et al (1998 to 2001) on twenty patients, in 
the Mofid pediatric hospital, Tehran has tried to describe 
the disease according to clinical, electrodiagnostical and 
neuro-imaging (15).
As known, MS is more common in women than in men; 
the sex ratio ranges between 1.9: 1 and 3. 1: 1, being 3: 
1 in our study. An increase in the female to male ratio in 
childhood cases has also been demonstrated in previous 
studies by Dequette & et al in 1987 (16) and Hanefeld in 
1993 (17). MS is an autoimmune disease and differences 
in sex ratios are the rule in autoimmune diseases (18). 
Sex hormones influence immunity, probably by acting 
on the thymus gland or on the T-lymphocyte subset. 
Female predominancy may suggest a role of hormonal 
changes in puberty in triggering MS onset, possibly by 
an influence on T-lymphocyte subsets (18,19).
The disease as it occurs in children does not appear 
to differ clinically from the disease observed in adults 
regarding the mode of onset, symptoms and physical 
findings. Just as in adults, evidence of weakness of 
limbs, incoordination, and visual disturbance and so 
on are present in the majority of instances seen among 
children (2).
In our study, the initial clinical manifestations were motor 
disturbances, diplopia, ataxia or incoordination. In their 
multicenter study of 125 patients with childhood MS, 
Duquette,et al (16) reported that sensory disturbances 
were the most common initial manifestation of disease, 
occurring in 26.4% of cases, followed by optic neuritis 
(14%), motor disturbances (11%), diplopia (11%), gait 
problems (8%) and cerebellar ataxia (5%). Among 
149 MS patients, with onset of disease before the age 
of 16 years, Ghezzi & et al (20) found that brainstem 
dysfunction (25%), as an initial symptom, was more 
frequent compared to other systems and onset of adult 
MS symptoms. In a recent study, Ruggieri & et al (21) 
found that ataxia was preponderant as an initial symptom 
in the group of childhood MS cases with onset before 
15 years of age. In that study, optic nerve involvement 
became more frequent with progressive age (21); in 
this age group, the disease was initiated by weakness, 
visual or sensory symptoms that would frequently remit 
completely and usually evolved in a relapsing remitting 
manner, although the course was initially progressive 
in some patients. The clinical course of childhood MS 
in literature (16,22,23) points out the preponderance 
of relapsing-remitting form ranging from 56 to 62.5% 
compared with our series (88%). In the same studies, 
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secondary progressive and primary progressive forms 
were reported in 22% and 25% of patients, respectively. 
In our study, two patients had primary progressive 
disease and one patient had chronic progressive disease 
(24).
In their multicenter study of 125 patients with childhood 
MS, Duquette & et al (16) reported a 21% prevalence 
of positive family history of MS. Our result with the 
prevalence of 11.5% was lower than that of the Duquette 
et al study and other previously reported studies (25).
MRI has demonstrated complete accuracy in defining MS 
plaques in adult onset MS. In our study, 100% of patients 
revealed characteristic abnormalities consistent with 
those lesions differentiated by MRI among adults; MRI 
therefore, seems to be a valuable diagnostic procedure 
in children as well as in adults. The same results can 
be seen in Sindern’s study, who observed characteristic 
MRI findings in 23 of 28 juvenile patients (16). In 
another study, Selcen & et al (26) reviewed 16 patients 
diagnosed as having MS before the age of 17 and they 
found that MRI was positive in 80% of patients.
Pohl & et al evaluated multimodal evoked potentials in 
pediatric patients with MS and showed abnormal EP in 
82% of the children. Our evaluation of evoked potentials 
showed abnormal EP in 70% of the children (27).
In our study, 23% of CSFs contained abnormal amounts 
of protein concentration over 40 mg/100 ml. Between 
40 to 90% of pediatric MS patients were reported to 
have increased intrathecal IgG synthesis, or production 
of myelin basis protein, or oligoclonal bands (OCB) in 
CSF. A retrospective analysis of 136 patients with MS 
with disease onset < 16 years showed that 92% had 
either an increased IgG index or OCB, with a sensitivity 
similiar to that observed in the adults (8).
In conclusion, clinical and demographic characteristics 
of our patients were similar to other reports; however, 
some differences existed.
The data presented indicate that from a clinical 
standpoint, multiple sclerosis does occur in children and 
is not so rare in childhood and although its diagnosis 
is essentially a clinical one, paraclinical investigations 
are of great value in the identification of demyelinating 
disorders in childhood.
Should a pediatrician encounter a child showing evidence 
of scattered neurological deficits that remit, particularly 
weakness, disturbance of vision and coordination, he or 
she should consider the possibility of MS. The possibility 
of other diseases also must be considered carefully. If 
specific treatment of MS becomes available, however, 
early diagnosis would appear to be important.
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